![](/img/cover-not-exists.png)
Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)
T. Schroeder, A.G. Czibere, N. Kröger, U. Platzbecker, G. Bug, L. Uharek, T. Luft, I. Bruns, F. Zohren, C. Wolschke, R. Fenk, R. Haas, G. KobbeVolume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2010.12.028
File:
PDF, 63 KB
english, 2011